H.C. Wainwright raises Rhythm Pharmaceuticals stock price target to $130 on Japan approval
Covered in this story
What has happened since
- Rhythm Pharmaceuticals Inc is down 3.6% since this was published.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
H.C. Wainwright’s $130 target on $RYTM is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
H.C. Wainwright’s track record →Call it yourself
No member calls on $RYTM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rhythm Pharmaceuticals Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.